No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs539535380 |
chr1:228254399-228254400 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs150333362 |
chr1:228254456-228254457 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs531409509 |
chr1:228254457-228254458 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs549616540 |
chr1:228254459-228254460 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs561506261 |
chr1:228254462-228254463 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs58793961 |
chr1:228254475-228254476 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs557776042 |
chr1:228254476-228254477 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs370046013 |
chr1:228254486-228254487 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs566531215 |
chr1:228254509-228254510 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs141222143 |
chr1:228254529-228254530 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs555648399 |
chr1:228254637-228254638 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs562206604 |
chr1:228254644-228254645 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs145363132 |
chr1:228254647-228254648 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs74143667 |
chr1:228254651-228254652 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs556379538 |
chr1:228254716-228254717 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs529331329 |
chr1:228254735-228254736 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs142354222 |
chr1:228254736-228254737 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs560243882 |
chr1:228254746-228254747 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs12161517 |
chr1:228254753-228254754 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs542225136 |
chr1:228254773-228254774 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs562428043 |
chr1:228254810-228254811 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs529544103 |
chr1:228254817-228254818 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs550802155 |
chr1:228254918-228254919 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs78627368 |
chr1:228254934-228254935 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs369277211 |
chr1:228254935-228254936 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs533303156 |
chr1:228254943-228254944 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs376212746 |
chr1:228254960-228254961 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs376820501 |
chr1:228254972-228254973 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs537675997 |
chr1:228254979-228254980 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs551466256 |
chr1:228254989-228254990 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs145925726 |
chr1:228255019-228255020 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs139656496 |
chr1:228255034-228255035 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs555451995 |
chr1:228255039-228255040 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs73092912 |
chr1:228255063-228255064 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs537742633 |
chr1:228255080-228255081 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs556446711 |
chr1:228255159-228255160 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs577918826 |
chr1:228255176-228255177 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs538797797 |
chr1:228255238-228255239 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs185018056 |
chr1:228255269-228255270 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs144564170 |
chr1:228255271-228255272 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs148451965 |
chr1:228255325-228255326 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs560711504 |
chr1:228255341-228255342 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs371249076 |
chr1:228255356-228255357 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs544506262 |
chr1:228255428-228255429 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs10916263 |
chr1:228255433-228255434 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs113062093 |
chr1:228255504-228255505 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs533361433 |
chr1:228255554-228255555 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs145202405 |
chr1:228255567-228255568 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs375727594 |
chr1:228255576-228255577 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs375609730 |
chr1:228255610-228255611 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|